EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Real-world Evidence of Self-reported Treatments, Signs, and Symptom Burden in Chronic Hand Eczema: Findings from the Multinational CHECK Study

Sonja Molin iD, Maria Concetta Fargnoli iD, Marie Noelle Crepy iD, Ana Maria Giménez-Arnau iD, Lysel Brignoli iD, Perrine Le Calvé iD, Michal Krupka iD, Jenny M Norlin iD, Christian Apfelbacher iD, Anthony Bewley iD

Acta Dermato-Venereologica · 2026

DOI: 10.2340/actadv.v106.44493 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Dermato-Venereologica, 2026. Verfasst von Sonja Molin und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Dermatology, Venerology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany; Division of Dermatology, Queen's University,…. Hauptthemen laut MEDLINE: Eczema, Hand Dermatoses, Self Report, Dermatologic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hand eczema is a multifactorial disease that can impact quality of life considerably. This observational questionnaire study aimed to investigate real-world treatments and patients’ experiences of disease burden across the broad severity spectrum represent-ed by the general chronic hand eczema population. The study included 1,948 individuals from 6 countries (mean age 43.2 years; 64.5% females) with self-reported physician-diagnosed chronic hand eczema. Ongoing treatment was reported in 68.6%, which included systemics or phototherapy (with or without topicals; 10.7%), topical corticosteroids (with or without additional topicals; 36.0%) and other topical treatments (no topical corticosteroids; 21.8%). At survey time, 43.0% were in flare state. About half, 51.1%, reported moderate to severe disease signs (past week). Treatment with topical corticosteroids was suboptimal in 9.7% of those with moderate to severe disease. Experience of symptoms was common, particularly itch. Symptom burden differed significantly between groups with different treatments and severity levels; it was highest among those reporting systemics/phototherapy and those for whom topical corticosteroids were suboptimal. The results indicate that, despite a high treatment rate, chronic hand eczema is associated with a considerable disease burden that varies significantly across the severity spectrum. A particularly high burden in treatment stages beyond topical corticosteroids indicates a need for more effective management of symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EczemaHand DermatosesSelf ReportDermatologic AgentsHumansFemaleMaleAdultMiddle AgedChronic DiseaseSeverity of Illness IndexAdrenal Cortex HormonesTreatment OutcomeQuality of LifePhototherapyAgedYoung AdultCost of IllnessPruritusSymptom Burden

Substanzen

Adrenal Cortex HormonesDermatologic Agents

Autor:innen und Institutionen

  • 1Department of Dermatology, Venerology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany; Division of Dermatology, Queen's University, Kingston, Canada. sonja-christine.molin@charite.de.
  • San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
  • Department of Occupational and Environmental Diseases, University Hospital of Centre of Paris, Hotel-Dieu Hospital, France; Department of Dermatology, University Hospital of Centre of Paris, Cochin Hospital, AP-HP, Pari…
  • Department of Dermatology, Hospital de Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
  • Oracle Life Sciences, Paris, France.
  • LEO Pharma A/S, Ballerup, Denmark.

ORCID-Profile: Sonja Molin, Maria Concetta Fargnoli, Marie Noelle Crepy, Ana Maria Giménez-Arnau, Lysel Brignoli, Perrine Le Calvé, Michal Krupka, Jenny M Norlin, Christian Apfelbacher, Anthony Bewley

Zitieren

APA

Molin, S., Fargnoli, M. C., Crepy, M. N., Giménez-Arnau, A. M., Brignoli, L., Le Calvé, P., Krupka, M., Norlin, J. M., Apfelbacher, C., & Bewley, A. (2026). Real-world Evidence of Self-reported Treatments, Signs, and Symptom Burden in Chronic Hand Eczema: Findings from the Multinational CHECK Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v106.44493

Vancouver

Molin S, Fargnoli MC, Crepy MN, Giménez-Arnau AM, Brignoli L, Le Calvé P, et al. Real-world Evidence of Self-reported Treatments, Signs, and Symptom Burden in Chronic Hand Eczema: Findings from the Multinational CHECK Study. Acta Dermato-Venereologica. 2026. doi:10.2340/actadv.v106.44493

BibTeX
@article{Molin2026,
  author = {Molin, Sonja and Fargnoli, Maria Concetta and Crepy, Marie Noelle and Giménez-Arnau, Ana Maria and Brignoli, Lysel and Le Calvé, Perrine and Krupka, Michal and Norlin, Jenny M and Apfelbacher, Christian and Bewley, Anthony},
  title = {Real-world Evidence of Self-reported Treatments, Signs, and Symptom Burden in Chronic Hand Eczema: Findings from the Multinational CHECK Study},
  journal = {Acta Dermato-Venereologica},
  year = {2026},
  doi = {10.2340/actadv.v106.44493}
}
Kostenlos starten →